En 1977, las sondas espaciales Voyager 1 y 2 de la NASA partieron de la Tierra. Ambas naves sobrevolaron planetas y satélites y luego salieron del sistema solar, alcanzando el espacio interestelar. Están más lejos de la Tierra que cualquier otro objeto de fabricación huma …
Se ha detectado, por vez primera fuera de la Tierra, un compuesto químico orgánico denominado 2-metoxietanol, también conocido como éter monometílico de etilenglicol. La detección se ha hecho en el transcurso de una investigación llevada a ca …
Detección interestelar de una rara sustancia orgánica Read More »
In a move that is set to transform clinical reproductive medicine, GenEmbryomics Limited and Progenesis Inc, today announced a groundbreaking collaboration to enhance access to cutting-edge reproductive technologies.
GenEmbryomics and Progenesis Announce Strategic Partnership to Transform IVF Testing Read More »
Innoviva Specialty Therapeutics, Inc., a subsidiary of Innoviva, Inc., announced that positive results from the Phase 3 oral zoliflodacin trial will be highlighted in an oral presentation given by the Global Antibiotic Research & Development Partnership at the European Society of Clinical Microbiology and Infectious Disease Global Congress taking place April 27-30, 2024, in Barcelona,
RedHill Biopharma Ltd. announced that the first patient has been enrolled in the Austere environments Consortium for Enhanced Sepsis Outcomes’ U.S. government-supported PROTECT multinational platform trial for early COVID-19 outpatient treatment.
RedHill Announces First Patient Enrolled in U.S. Government-Supported COVID-19 Study Read More »
While Sanofi restructures and parts with employees from U.S. and Belgian sites, a new company in the GLP-1 space emerges from stealth.
Sanofi Layoffs, CAR-T Warnings and a New GLP-1 Player Read More »
Meihua International Medical Technologies Co., Ltd., a reputable manufacturer and provider of Class I, II, and III disposable medical devices with operating subsidiaries in China, reported its financial results for the fiscal year ended December 31, 2023.
Meihua International Medical Technologies Co., Ltd. Reports 2023 Financial Year Results Read More »
REGENXBIO Inc. announced it will participate in Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit on Monday, April 29, 2024.
Alkermes plc announced initiation of the Vibrance-1 study, a phase 2 clinical trial evaluating the safety and efficacy of ALKS 2680 compared to placebo in patients with narcolepsy type 1.
Calliditas Therapeutics AB, announced that the global open-label extension study to the Phase 3 NefIgArd study showed a treatment response consistent with the NefIgArd study across endpoints of urine protein to creatinine ration and estimated glomerular filtration rate at 9 months across all IgAN patients, including those who had previously received Nefecon in the NefIgArd
Calliditas Announces Positive NefIgArd Open Label Extension Results Read More »
